- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Stem Cells International
Volume 2013 (2013), Article ID 985285, 12 pages
Increased Haematopoietic Supportive Function of USSC from Umbilical Cord Blood Compared to CB MSC and Possible Role of DLK-1
Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich Heine University Medical Center, 40225 Duesseldorf, Germany
Received 11 October 2012; Revised 25 January 2013; Accepted 7 March 2013
Academic Editor: David Allan
Copyright © 2013 Simone Maria Kluth et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- G. Kögler, T. F. Radke, A. Lefort et al., “Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells,” Experimental Hematology, vol. 33, no. 5, pp. 573–583, 2005.
- G. Kögler, S. Sensken, J. A. Airey et al., “A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential,” Journal of Experimental Medicine, vol. 200, no. 2, pp. 123–135, 2004.
- S. M. Kluth, A. Buchheiser, A. P. Houben et al., “DLK-1 as a marker to distinguish unrestricted somatic stem cells and mesenchymal stromal cells in cord blood,” Stem Cells and Development, vol. 19, no. 10, pp. 1471–1483, 2010.
- S. Liedtke, A. Buchheiser, J. Bosch et al., “The HOX Code as a “biological fingerprint” to distinguish functionally distinct stem cell populations derived from cord blood,” Stem Cell Research, vol. 5, no. 1, pp. 40–50, 2010.
- Y. J. Chang, D. T. B. Shih, C. P. Tseng, T. B. Hsieh, D. C. Lee, and S. M. Hwang, “Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood,” Stem Cells, vol. 24, no. 3, pp. 679–685, 2006.
- D. T. Covas, R. A. Panepucci, A. M. Fontes et al., “Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts,” Experimental Hematology, vol. 36, no. 5, pp. 642–654, 2008.
- S. E. Yang, C. W. Ha, M. H. Jung et al., “Mesenchymal stem/progenitor cells developed in cultures from UC blood,” Cytotherapy, vol. 6, no. 5, pp. 476–486, 2004.
- M. Karagianni, I. Brinkmann, S. Kinzebach, et al., “A comparative analysis of the adipogenic potential in human mesenchymal stromal cells from cord blood and other sources,” Cytotherapy, vol. 15, no. 1, pp. 76–88, 2012.
- M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006.
- A. I. Caplan, “Mesenchymal stem cells,” Journal of Orthopaedic Research, vol. 9, no. 5, pp. 641–650, 1991.
- P. Bianco, P. G. Robey, I. Saggio, and M. Riminucci, “‘Mesenchymal’ stem cells in human bone marrow (Skeletal Stem Cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease,” Human Gene Therapy, vol. 21, no. 9, pp. 1057–1066, 2010.
- C. M. Smas and H. S. Sul, “Characterization of pref-1 and its inhibitory role in adipocyte differentiation,” International Journal of Obesity, vol. 20, supplement 3, pp. S65–S72, 1996.
- C. M. Smas and H. S. Sul, “Molecular mechanisms of adipocyte differentiation and inhibitory action of pref-1,” Critical Reviews in Eukaryotic Gene Expression, vol. 7, no. 4, pp. 281–298, 1997.
- Y. Wang and H. S. Sul, “Pref-1 regulates mesenchymal cell commitment and differentiation through Sox9,” Cell Metabolism, vol. 9, no. 3, pp. 287–302, 2009.
- S. Chou and H. F. Lodish, “Fetal liver hepatic progenitors are supportive stromal cells for hematopoietic stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 17, pp. 7799–7804, 2010.
- K. A. Moore, B. Pytowski, L. Witte, D. Hicklin, and I. R. Lemischka, “Hematopoietic activity of a stromal cell transmembrane protein containing epidermal growth factor-like repeat motifs,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 8, pp. 4011–4016, 1997.
- N. Ohno, A. Izawa, M. Hattori, R. Kageyama, and T. Sudo, “dlk inhibits stem cell factor-induced colony formation of murine hematopoietic progenitors: Hes-1-independent effect,” Stem Cells, vol. 19, no. 1, pp. 71–79, 2001.
- C. H. Jensen, T. N. Krogh, P. Hojrup et al., “Protein structure of fetal antigen 1 (FA1)—a novel circulating human epidermal-growth-factor-like protein expressed in neuroendocrine tumors and its relation to the gene products of dlk and pG2,” European Journal of Biochemistry, vol. 225, no. 1, pp. 83–92, 1994.
- J. Bosch, A. P. Houben, T. F. Radke, et al., “Distinct differentiation potential of, “MSC” derived from cord blood and umbilical cord: are cord-derived cells true mesenchymal stromal cells?” Stem Cells and Development, vol. 21, no. 11, pp. 1977–1988, 2012.
- C. M. Smas, L. Chen, and H. S. Sul, “Cleavage of membrane-associated pref-1 generates a soluble inhibitor of adipocyte differentiation,” Molecular and Cellular Biology, vol. 17, no. 2, pp. 977–988, 1997.
- B. Mei, L. Zhao, L. Chen, and H. S. Sul, “Only the large soluble form of preadipocyte factor-1 (Pref-1), but not the small soluble and membrane forms, inhibits adipocyte differentiation: role of alternative splicing,” Biochemical Journal, vol. 364, part 1, pp. 137–144, 2002.
- K. S. Jeltsch, T. F. Radke, S. Laufs et al., “Unrestricted somatic stem cells: Interaction with CD34+ cells in vitro and in vivo, expression of homing genes and exclusion of tumorigenic potential,” Cytotherapy, vol. 13, no. 3, pp. 357–365, 2011.
- D. Kent, M. Copley, C. Benz, B. Dykstra, M. Bowie, and C. Eaves, “Regulation of hematopoietic stem cells by the steel factor/KIT signaling pathway,” Clinical Cancer Research, vol. 14, no. 7, pp. 1926–1930, 2008.
- K. Kita, J. O. Lee, C. C. Finnerty, and D. N. Herndon, “Cord blood-derived hematopoietic stem/progenitor cells: current challenges in engraftment, infection, and ex vivo expansion,” Stem Cells International, vol. 2011, Article ID 276193, 8 pages, 2011.
- R. Möhle, F. Bautz, S. Rafii, M. A. S. Moore, W. Brugger, and L. Kanz, “The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1,” Blood, vol. 91, no. 12, pp. 4523–4530, 1998.
- Y. Nie, Y. C. Han, and Y. R. Zou, “CXCR4 is required for the quiescence of primitive hematopoietic cells,” Journal of Experimental Medicine, vol. 205, no. 4, pp. 777–783, 2008.
- B. M. Abdallah, M. Ding, C. H. Jensen et al., “Dlk1/FA1 is a novel endocrine regulator of bone and fat mass and its serum level is modulated by growth hormone,” Endocrinology, vol. 148, no. 7, pp. 3111–3121, 2007.
- S. J. Bray, S. Takada, E. Harrison, S. C. Shen, and A. C. Ferguson-Smith, “The atypical mammalian ligand Delta-like homologue 1 (Dlk1) can regulate Notch signalling in Drosophila,” BMC Developmental Biology, vol. 8, article 11, 2008.
- R. Le Borgne, “Regulation of Notch signalling by endocytosis and endosomal sorting,” Current Opinion in Cell Biology, vol. 18, no. 2, pp. 213–222, 2006.
- B. M. Abdallah, C. H. Jensen, G. Gutierrez, R. G. Q. Leslie, T. G. Jensen, and M. Kassem, “Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1,” Journal of Bone and Mineral Research, vol. 19, no. 5, pp. 841–852, 2004.
- S. Guller, M. Sonenberg, K. Y. Wu, P. Szabo, and R. E. Corin, “Growth hormone-dependent events in the adipose differentiation of 3T3-F442A fibroblasts: modulation of macromolecular synthesis,” Endocrinology, vol. 125, no. 5, pp. 2360–2367, 1989.
- P. J. Smith, L. S. Wise, R. Berkowitz, C. Wan, and C. S. Rubin, “Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes,” The Journal of Biological Chemistry, vol. 263, no. 19, pp. 9402–9408, 1988.
- M. L. Nueda, J. J. García-Ramírez, J. Laborda, and V. Baladrón, “dlk1 specifically interacts with insulin-like growth factor binding protein 1 to modulate adipogenesis of 3T3-L1 cells,” Journal of Molecular Biology, vol. 379, no. 3, pp. 428–442, 2008.